COVID-19:Ushio的病毒灭活模块:222nm / UV灭菌

COVID-19:Ushio的病毒灭活模块:222nm / UV灭菌

新型冠状病毒肺炎(COVID-19):新冠肺炎(COVID-19):COVID-19:

Ushio America,Inc .:

供应给美国主要照明设备制造商
与Acuity Brands签订合同
2020年下半年在北美商业化

“ Care222TM”:

5月20日,我们与美国Acuity Brands,Inc.签订了222nm UV杀菌/病毒灭活模块的供应合同。

“ Care222TM”通过用222 nm紫外线照射来灭活病毒和细菌并对其进行灭菌。

敏锐品牌有限公司

将Care222 TM模块安装在您自己的照明设备中。

在有人/无人环境中使用此照明,
对于附着在墙壁/地板/门把手上的病毒/细菌,
开发灭活和消毒的产品
计划从2020年下半年开始在北美开始销售(计划用于办公室,商业设施,学校,公共设施等)

牛尾的目标:

专注于紫外线的影响,我们多年来一直在开发Care222 TM模块。

灯具制造商
卫生设备制造商
针对电器制造商
我们提供广泛的Care222TM模块,以帮助降低感染病毒和细菌的风险并预防大流行。

■视力新闻稿(英文)

■通过222nm UV进行消毒和病毒灭活技术

牛尾电机

https://www.ushio.co.jp/jp/news/1002/2020-2020/500640.html

Acuity Brands Announces Agreement with Ushio America, Inc. NYSE:AYI

June 01, 2020 08:15 ET | Source: Acuity Brands, Inc.

Atlanta, June 01, 2020 (GLOBE NEWSWIRE) —

Acuity Brands, Inc. (NYSE: AYI)

today announced it has entered into a strategic alliance agreement with Ushio America, Inc.(Ushio).

Ushio has agreed

to supply Acuity Brands with its Care222® UV disinfection module, which uses filtered excimer lamps to generate 222nm far-UVC light capable of inactivating viruses and bacteria on indoor surfaces.

Acuity Brands plans

to incorporate these lamps in a range of its products, including its ceiling and wall-mounted lighting fixtures that can operate in occupied or unoccupied spaces, to reduce pathogens.

The agreement is exclusive

to Acuity Brands for general illumination uses throughout North America.

Acuity Brands also

has non-exclusive rights to use the Care222 disinfection module worldwide (except Asia) for lighting and other uses.

When incorporated in Acuity Brands products and used with its control systems, which are commonly installed in spaces

such as offices,

  1. classrooms,
  2. restaurants,
  3. retail stores,
  4. restrooms and other public facilities,

the Care222 lamp module

will emit intermittent pulses of the 222nm UV light to reduce pathogens on surfaces.

The mercury-free Care222 excimer lamps produced by Ushio

feature a specially designed short pass filter, based on groundbreaking research and technology

developed by Columbia University, which filters out from the lamp the longer UV wavelengths that are harmful to humans.

The result is a narrow band 222nm wavelength of UV light that can inactivate viruses and bacteria, effectively preventing them from replicating.

Results from laboratory testing and clinical studies suggest that

the filtered UV light emitted from the Care222 lamp can reduce pathogens on surfaces without posing a health risk to human skin or eyes when used within appropriate parameters.

In contrast, possible acute and chronic damage to eyes and skin may result from the more generally employed 254nm UV wavelength used in many germicidal lamps,

although this UV wavelength can be used in interior spaces under certain conditions that sharply limit human exposure.

In addition,

although lamps in the 405-430nm wavelength range can also be used in occupied spaces, they are not as effective against viruses as lamps with lower-range UVC wavelengths.

“In recent years,

it has become increasingly paramount to find new, safer methods of reducing pathogens on surfaces throughout the day,” said Acuity Brands Lighting Senior Vice President, Rick Earlywine.

We are excited about incorporating the Care222 UV light module into our lighting fixtures for use in both occupied and unoccupied spaces.

Using this module in our leading lighting fixtures installed in a space represents a significant advancement in protecting public areas against bacteria and viruses.”

https://www.globenewswire.com/news-release/2020/06/01/2041460/0/en/Acuity-Brands-Announces-Agreement-with-Ushio-America-Inc.html